BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
Sidoti Events, LLC's August Micro-Cap Virtual Conference
Aspire Biopharma is scheduled to present at the Sidoti Events August Micro-Cap Virtual Investor Conference on August 19, 2026.
The company's presentation is set for Wednesday between 1:45 PM and 2:15 PM ET, targeting investors focused on the small and micro-cap sector.
Sidoti & Company, the organizer, provides research and corporate access for companies typically in the $200 million to $5 billion market cap range.